<DOC>
	<DOCNO>NCT00187265</DOCNO>
	<brief_summary>The purpose study evaluate feasibility permanent biventricular pace use three ventricular lead , efficacy term inter intra-ventricular resynchronization , patient congestive heart failure non-functional atrium ( chronic AF ) .</brief_summary>
	<brief_title>Trip HF Study : Triple Resynchronization Paced Heeart Failure Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>• NYHA class III–IV congestive heart failure , spite optimal medical treatment congestive heart failure 1 month . The medical treatment must include 40 mg/day minimum dose furosemide ( equivalent ) ; Permanent atrial fibrillation ( AF ) ; Left ventricular ejection fraction ( LVEF ) ≤ 35 % ; Indication pacemaker implantation permanent symptomatic bradycardia , already implant pacemaker condition lead position corresponds criterion describe protocol ; Aortic preejection delay least equal 140 m . Indication cardiac defibrillator ; Having present myocardial infarct within previous 3 month ; Having undergone cardiac surgery coronary revascularization procedure within previous 3 month , schedule procedure ; Presenting chronic pulmonary insufficiency ; Patients whose congestive heart failure require use intravenous inotropic support ; Presenting dysthyreosis ; Having life expectancy le one year , reason congestive heart failure ; Unable followedup scope study geographical reason ; Having refuse give consent ; Minors ( age &lt; 18 year ) pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2006</verification_date>
</DOC>